We here identified a bivalent carboxylate inhibitor, previously developed as a molecule to disrupt MMP-9 homodimerization in models for cancer cell migration [26], as a highly specific subnanomolar inhibitor for the stable trimeric proteoform of MMP-9 (IC50 = ±0.1 nM). The gene discussed is MMP9; the disease is cancer.